UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fosaprepitant and aprepitant: an update of the evidence for their place in the prevention of chemotherapy-induced nausea and vomiting

Core evidence, 2010-01, Vol.5, p.77-90

2010

Volltextzugriff (PDF)

NICE supports shared decision making

BMJ (Online), 2019-03, p.l1038

2019

Volltextzugriff (PDF)

Banbury Forum Consensus Statement on the Path Forward for Digital Mental Health Treatment

Psychiatric services (Washington, D.C.), 2021-06, Vol.72 (6), p.677-683

2021

Volltextzugriff (PDF)

OP33 Adopting Health Technologies: NICE Approach For Evidence Into Action

International journal of technology assessment in health care, 2018, Vol.34 (S1), p.13-14

2018

Volltextzugriff (PDF)

Aprepitant: the evidence for its place in the prevention of chemotherapy-induced nausea and vomiting

Core evidence, 2007-01, Vol.2 (1), p.15-30

Chrisp, Paul

2007

Volltextzugriff (PDF)

Rimonabant: the evidence for its use in the treatment of obesity and the metabolic syndrome

Core evidence, 2008-02, Vol.2 (3), p.173-187

2008

Volltextzugriff (PDF)

Reaching a shared understanding of shared decision making in health care: NICE's experience of scoping the shared decision making guideline

Journal of evaluation in clinical practice, 2019-12, Vol.25 (6), p.1027-1029

2019

Volltextzugriff (PDF)

Medicines and prescribing support online from NICE

Prescriber (London, England), 2013-06, Vol.24 (11), p.40-42

Chrisp, Paul

2013

Volltextzugriff (PDF)

Bevacizumab: the evidence for its clinical potential in the treatment of nonsmall cell lung cancer

Core evidence, 2007-01, Vol.2 (1), p.31-49

2007

Volltextzugriff (PDF)

Lumiracoxib: the evidence of its clinical impact on the treatment of osteoarthritis

Core evidence, 2007-11, Vol.2 (2), p.131-150

2007

Volltextzugriff (PDF)

Vildagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus

Core evidence, 2008-12, Vol.3, p.0

2008

Volltextzugriff (PDF)

Aripiprazole: the evidence of its therapeutic impact in schizophrenia

Core evidence, 2006-01, Vol.1 (4), p.251-264

2006

Volltextzugriff (PDF)

Ciclesonide in persistent asthma: the evidence of its therapeutic value

Core evidence, 2006-01, Vol.1 (4), p.233-249

2006

Volltextzugriff (PDF)

Lamotrigine : a review of its pharmacological properties and clinical efficacy in epilepsy

Drugs (New York, N.Y.), 1993-07, Vol.46 (1), p.152-176

1993

Volltextzugriff (PDF)

Vildagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus

Core evidence, 2008-06, Vol.3 (1), p.13-30

2008

Volltextzugriff (PDF)

Rimonabant: the evidence for its use in the treatment of obesity and the metabolic syndrome

Core evidence, 2007-01, Vol.2 (3), p.173-187

2007

Volltextzugriff (PDF)

Foscarnet : a review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis

Drugs (New York, N.Y.), 1991, Vol.41 (1), p.104-129

1991

Volltextzugriff (PDF)

Mitoxantrone : a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer

Drugs (New York, N.Y.), 1991-03, Vol.41 (3), p.400-449

1991

Volltextzugriff (PDF)

Etanercept in psoriasis: the evidence of its therapeutic impact

Core evidence, 2007-01, Vol.2 (1), p.51-62

Thomson, Andrew

2007

Volltextzugriff (PDF)

Moxonidine : a review of its pharmacology, and therapeutic use in essential hypertension

Drugs (New York, N.Y.), 1992-12, Vol.44 (6), p.993-1012

1992

Volltextzugriff (PDF)

Bortezomib: the evidence of its clinical impact in multiple myeloma

Core evidence, 2006-01, Vol.1 (4), p.265-277

Lancaster, Simon

2006

Volltextzugriff (PDF)

Perindopril: the evidence of its therapeutic impact in hypertension

Core evidence, 2007-01, Vol.2 (1), p.63-79

2007

Volltextzugriff (PDF)

Obtaining optimal outcomes in the ‘post-antibacterial era’

PharmacoEconomics & outcomes news, 1996-07, Vol.69 (1), p.3-4

Chrisp, Paul

1996

Volltextzugriff (PDF)

Mycophenolate mofetil suppresses costs and graft rejection

PharmacoEconomics & outcomes news, 1996-06, Vol.68 (1), p.3-3

Chrisp, Paul

1996

Volltextzugriff (PDF)

The pathway to successful health outcomes

PharmacoEconomics & outcomes news, 1996-06, Vol.67 (1), p.3-4

Chrisp, Paul

1996

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(26)

Publikationsform

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fosaprepitant and aprepitant: an update of the evidence for their place in the prevention of chemotherapy-induced nausea and vomiting

NICE supports shared decision making

Banbury Forum Consensus Statement on the Path Forward for Digital Mental Health Treatment

OP33 Adopting Health Technologies: NICE Approach For Evidence Into Action

Aprepitant: the evidence for its place in the prevention of chemotherapy-induced nausea and vomiting

Rimonabant: the evidence for its use in the treatment of obesity and the metabolic syndrome

Reaching a shared understanding of shared decision making in health care: NICE's experience of scoping the shared decision making guideline

Medicines and prescribing support online from NICE

Bevacizumab: the evidence for its clinical potential in the treatment of nonsmall cell lung cancer

Lumiracoxib: the evidence of its clinical impact on the treatment of osteoarthritis

Vildagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus

Aripiprazole: the evidence of its therapeutic impact in schizophrenia

Ciclesonide in persistent asthma: the evidence of its therapeutic value

Lamotrigine : a review of its pharmacological properties and clinical efficacy in epilepsy

Vildagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus

Rimonabant: the evidence for its use in the treatment of obesity and the metabolic syndrome

Foscarnet : a review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis

Mitoxantrone : a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer

Etanercept in psoriasis: the evidence of its therapeutic impact

Moxonidine : a review of its pharmacology, and therapeutic use in essential hypertension

Bortezomib: the evidence of its clinical impact in multiple myeloma

Perindopril: the evidence of its therapeutic impact in hypertension

Obtaining optimal outcomes in the ‘post-antibacterial era’

Mycophenolate mofetil suppresses costs and graft rejection

The pathway to successful health outcomes

Suchergebnisse filtern